Company intelligence / Profile preview

2Blades

Evanston, Illinois, USA2blades.org ↗

Ownership: Private
Development stage: Commercial

Overview

2Blades has successfully demonstrated new disease resistance options for wheat, soybean, potato, and tomato in the lab, greenhouse, and field settings. Their work includes enabling technologies like TALENs used to create new traits in major crops. They have advanced resistance genes against Asian soybean rust in Brazil, stem rust in wheat globally, and late blight in potato—delivering cultivars with durable resistance especially targeted at food security challenges.

Therapeutic areas: OtherInfectious Diseases
Modalities: Gene editing (e.g., TALEN gene-editing platform)Genetic trait engineeringResistance gene stacking
Industry: Agriculture & AgTech

Partnerships

Bayer CropScienceMonsantoInternational Potato Center/CIP ("End the Blight" campaign)CIMMYTBGRI

Beyond the preview

Go deeper on 2Blades.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2Blades.

Explore the full profile